Clinical significance of uric acid dihydrate in urinary stones

被引:8
|
作者
Strohmaier, Walter Ludwig [1 ]
Seilnacht, Juergen [1 ]
Schubert, Gernot [2 ]
机构
[1] Klinikum Coburg, Dept Urol & Paediat Urol, RegioMed Kliniken, D-96450 Coburg, Germany
[2] Vivantes MVZ GmbH Med Versorgungszentrum Friedruc, Urinary Stone Lab, Lab Diagnost, Berlin, Germany
来源
UROLOGICAL RESEARCH | 2011年 / 39卷 / 05期
关键词
Uric acid; Uric acid dihydrate; Urolithiasis; Nephrolithiasis; Recurrence; Urinary calcium; Urine pH; NEPHROLITHIASIS; CALCULI; VOLUME;
D O I
10.1007/s00240-010-0356-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Uric acid crystallizes as an anhydrous compound (UAA), a dihydrate (UAD) or a mixture of both. A monohydrate form is very rare. About 20% of uric acid stones contain a significant amount (>= 20%) UAD. It is believed that UAD crystallizes under highly acidic conditions (urine pH <= 5.0). Up to now, metabolic data on patients with UAD stones have not been reported in the literature. One hundred and fifty patients with pure uric acid calculi were studied. Stone analysis was performed using X-ray diffraction. According to the stone analysis, they were divided in two groups: 1. UAD (>= 20% UAD), 2. UAA (<20% UAD). In all patients the following parameters were examined: age, sex, number of recurrences, body mass index (BMI); blood: creatinine, uric acid, calcium, sodium, and potassium; urine: pH-profiles, volume, calcium, uric acid, citrate, ammonia, and urea. Group 1 (>= 20% UAD) consisted of 33 patients and group 2 (<20% UAD) of 117 patients. Between these groups, there was a significant difference concerning the number of recurrences, the urine volume, and the urinary excretion of calcium. Patients with >= 20% dihydrate had a mean BMI of 31.6 +/- 7.5, a mean number of recurrences of 0.24 +/- 0.44, an urine volume of 2.6 +/- 0.8 l/24 h, and a calcium excretion of 4.5 +/- 2.2 mmol/24 h, whereas those with <20% dihydrate had BMI of 29.9 +/- 5.0, 1.10 +/- 1.42 recurrences, urine volume of 2.3 +/- 1.2 l/24 h, and calcium excretion of 3.2 +/- 2.4 mmol/24 h. All the other parameters tested were not significantly different. For the first time, our study shows metabolic data in uric acid patients with a significant amount of UAD. The comparison between this group and those patients with <20% UAD revealed that the first group is less prone to develop recurrences. This is a relevant difference concerning the necessity of metaphylactic measures. We could not confirm in patients with dihydrate if the urinary pH is more acid than in those with insignificant amounts of dihydrate. The higher 24-h urine volume, the higher excretion of calcium, and the higher BMI in the UAD group may be of pathophysiological relevance and requires further attention.
引用
收藏
页码:357 / 360
页数:4
相关论文
共 50 条
  • [31] Medical treatment of urinary stones
    Skolarikos, Andreas
    CURRENT OPINION IN UROLOGY, 2018, 28 (05) : 403 - 407
  • [32] Theobromine for treatment of uric acid stones and other diseases
    Trinchieri, Alberto
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2024, 96 (04)
  • [33] The impact of stenting prior to oral chemolysis of upper urinary tract uric acid stones
    Arman Tsaturyan
    Piet Bosshard
    Elizaveta Bokova
    Olivier Bonny
    Kevin Stritt
    Beat Roth
    International Urology and Nephrology, 2022, 54 : 37 - 45
  • [34] A new method for predicting uric acid composition in urinary stones using routine single-energy CT
    Mats Lidén
    Urolithiasis, 2018, 46 : 325 - 332
  • [35] Local Factors Compared with Systemic Factors in the Formation of Bladder Uric Acid Stones
    Li, Wei-Ming
    Chou, Yii-Her
    Li, Ching-Chia
    Liu, Chia-Chu
    Huang, Shu-Pin
    Wu, Wen-Jeng
    Huang, Chun-Hsiung
    UROLOGIA INTERNATIONALIS, 2009, 82 (01) : 48 - 52
  • [36] Kinetics and enthalpy of crystallization of uric acid dihydrate
    Sadovska, Galina
    Honcova, Pavla
    Sadovsky, Zdenek
    THERMOCHIMICA ACTA, 2013, 566 : 211 - 213
  • [37] Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis
    Strohmaier, Walter Ludwig
    Wrobel, Beate Maria
    Schubert, Gernot
    UROLOGICAL RESEARCH, 2012, 40 (02): : 171 - 175
  • [38] Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones
    Goldfarb, David S.
    MacDonald, Patricia A.
    Gunawardhana, Lhanoo
    Chefo, Solomon
    McLean, Lachy
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (11): : 1960 - 1967
  • [39] Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis
    Walter Ludwig Strohmaier
    Beate Maria Wrobel
    Gernot Schubert
    Urological Research, 2012, 40 : 171 - 175
  • [40] The safety of ureteral stenting with the use of potassium citrate for management of renal uric acid stones
    Alenezi, Nawaf Abdulaziz
    Zanaty, Fouad
    Hodhod, Amr
    El-Gharabawy, Mohammed
    El-Sherif, Eid
    Badawy, Atef
    Elshazly, Mohamed
    UROLOGY ANNALS, 2020, 12 (01) : 37 - 41